Overview of candidate therapies for COVID-19

Candidate therapies


The following queries provide an overview of small organic-molecule/peptide based therapies for coronavirus, resulting from the intersection of key-word search terms for the disease and the IPC and CPC classes A61K31, A61K38 and A61K45/06 for the compounds. Antibodies and nucleic acids are not included in this analysis, see the fourth accordion below: “Nucleic acids and antibodies to fight coronavirus”.

For a general overview of candidate therapies for diseases caused by coronaviruses in general, see here:

Patent analytics gives a deeper dive into the patent landscape. Our patent analysts have created a spreadsheet containing all the search strategies and datasets for patents for candidate therapies for fighting diseases caused by coronaviruses, as well as additional statistics in one place for you to download. You can also run the search strategies on your own platform or analyse the datasets yourself. If you are not familiar with how to write or adapt search strategies, our Espacenet pocket guide will help.

The use of the EPO’s website, downloads, data and information tools are subject to the EPO’s standard terms and conditions. See especially the terms of use for Espacenet